Smit B J, Kok J H, de Vries L S, van Wassenaer A G, Dekker F W, Ongerboer de Visser B W
Department of Neonatology, Emma Children's Hospital AMC, University of Amsterdam, Amsterdam, The Netherlands.
Pediatrics. 1998 May;101(5):865-9. doi: 10.1542/peds.101.5.865.
To study the effect of L-thyroxine supplementation on neurologic maturation in very preterm infants with transient hypothyroxinemia.
Randomized, double-blind, placebo-controlled, L-thyroxine supplementation trial.
Level III neonatal intensive care unit.
A total of 200 infants <30 weeks' gestational age.
Subjects were randomly assigned to receive L-thyroxine (8 microg/kg birth weight per day) or a placebo during the first 6 weeks of life.
Median nerve somatosensory evoked potentials were recorded, measuring cortical N1 peak latency at 2 weeks of age, at term, and at 6 months (corrected) age.
Cortical N1 peak latency was not decreased significantly in the L-thyroxine group compared with the placebo group throughout the study period.
L-Thyroxine supplementation during the first 6 weeks of life did not decrease cortical N1 peak latency in infants of <30 weeks' gestational age.